Perceptive Advisors »

Maplight Therapeutics shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.7M 550k 17.57

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Celcuity (CELC)
Rhythm Pharmaceuticals (RYTM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apogee Therapeutics (APGE)
Roivant Sciences SHS (ROIV)
Nuvalent Inc-a (NUVL)
Travere Therapeutics (TVTX)
Spdr Series Trust State Street Spd Put Option (XBI)
EXACT Sciences Corporation (EXAS)
Protagonist Therapeutics (PTGX)
Inhibrx Biosciences (INBX)
Edgewise Therapeutics (EWTX)
Immatics SHS (IMTX)
Spyre Therapeutics Com New (SYRE)

View all positions for Perceptive Advisors

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
T. Rowe Price Investment Management
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Perceptive Advisors
Velan Capital Investment Management
Siren
Geode Capital Management
Vestal Point Capital

View all funds holding Maplight Therapeutics